MarketCap
Facebook
X
Telegram
AxoGen ROA Ratio | AXGN
Annual ROA Ratio AxoGen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.08 | -4.89 | -11.03 | -14.82 | -12.97 | -11.81 | -18.84 | -13.98 | -17.74 | -31.08 | -35.57 | -107.99 | -52.58 | -46.55 | -73.78 | -84.66 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -4.89 | -107.99 | -34.09 |
Quarterly ROA Ratio AxoGen
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.77 | -12.87 | -12.09 | -7.28 | -1.12 | -2.42 | -3.72 | -5.32 | -7.52 | -8.65 | -11.11 | -11.29 | -12.08 | -12.19 | -12.66 | -14.72 | -14.49 | -15.68 | -15.49 | -13.07 | -13.51 | -10.87 | -11.89 | -14.17 | -15.74 | -18.59 | -18.3 | -18.57 | -17.28 | -16.2 | -16.35 | -20.66 | -21.64 | -24.13 | -24.32 | -22.79 | -30.68 | -33.14 | -37.15 | -39.43 | -37.13 | -36.92 | -40.65 | -42.38 | -72.12 | -80.95 | -85.1 | -89.65 | -64.91 | -60.74 | -66.1 | -68.1 | -73.23 | -84.37 | -72.78 | -73.65 | -70.78 | -71.54 | -77.53 | -75.73 | -23.84 | -16.45 | -18.34 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -1.12 | -89.65 | -32.3 |
ROA Ratio of other stocks in the Medical devices industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Zynex
ZYXI
|
2.45 | - | - | $ 21.1 M |  USA |
 |
Abiomed
ABMD
|
8.16 | - | - | $ 17.2 B | USA |
 |
Allied Healthcare Products
AHPI
|
-9.84 | - | 3.58 % | $ 2.21 M | USA |
 |
Titan Medical
TMDI
|
-31.46 | - | -26.32 % | $ 19.6 M |  Canada |
 |
Natus Medical Incorporated
NTUS
|
2.34 | - | 1.94 % | $ 1.05 B | USA |
 |
Nemaura Medical
NMRD
|
-97.12 | - | -17.8 % | $ 2.74 M |  Britain |
 |
Butterfly Network
BFLY
|
-26.0 | $ 6.5 | -2.1 % | $ 1.61 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-0.85 | - | - | $ 3.31 B | USA |
 |
Invacare Corporation
IVC
|
-2.67 | - | - | $ 24.7 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-0.12 | $ 8.45 | -1.97 % | $ 616 M |  Israel |
 |
Beyond Air
XAIR
|
-93.96 | $ 2.52 | 10.34 % | $ 20.9 B | USA |
 |
Alphatec Holdings
ATEC
|
-18.12 | $ 6.99 | -5.35 % | $ 1.05 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-8.34 | - | - | $ 1.77 B | USA |
 |
Bio-Rad Laboratories
BIO
|
7.18 | $ 388.54 | 0.06 % | $ 10.6 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-53.6 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
-116.17 | - | -5.86 % | $ 30.6 M | USA |
 |
Aethlon Medical
AEMD
|
-112.92 | $ 5.53 | 0.73 % | $ 3.73 M | USA |
 |
Apyx Medical Corporation
APYX
|
-16.77 | $ 2.95 | 0.34 % | $ 121 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-14.3 | $ 67.19 | -1.94 % | $ 1.99 B |  Costa-rica |
 |
Delcath Systems
DCTH
|
2.18 | $ 20.08 | -0.96 % | $ 719 M | USA |
 |
Electromed
ELMD
|
17.05 | $ 27.2 | 1.29 % | $ 225 M | USA |
 |
Inogen
INGN
|
7.62 | $ 6.02 | -1.64 % | $ 160 M | USA |
 |
Globus Medical
GMED
|
10.14 | $ 75.35 | -1.34 % | $ 10.2 B | USA |
 |
IRadimed Corporation
IRMD
|
20.67 | $ 86.87 | -0.08 % | $ 1.11 B | USA |
 |
ClearPoint Neuro
CLPT
|
-26.13 | $ 8.79 | -4.2 % | $ 249 M | USA |
 |
Accuray Incorporated
ARAY
|
-11.09 | $ 3.17 | -17.02 % | $ 389 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-86.69 | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
-15.22 | $ 0.7 | -0.41 % | $ 11.9 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-18.56 | $ 5.81 | -0.34 % | $ 362 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-14.35 | $ 14.54 | 1.18 % | $ 1.11 B | USA |
 |
Bruker Corporation
BRKR
|
-0.13 | $ 62.25 | -5.4 % | $ 9.45 B | USA |
 |
LivaNova PLC
LIVN
|
-9.31 | $ 91.39 | -1.32 % | $ 4.99 B | Britain |
|
LENSAR
LNSR
|
-47.99 | $ 4.97 | -8.97 % | $ 59.4 M | USA |
 |
Orthofix Medical
OFIX
|
-10.84 | $ 7.12 | -9.94 % | $ 282 M |  Curacao |
 |
Pulmonx Corporation
LUNG
|
-41.77 | $ 2.81 | 0.18 % | $ 114 M | USA |
 |
InspireMD
NSPR
|
-70.3 | $ 0.78 | 9.49 % | $ 50.2 M | Israel |
 |
InMode Ltd.
INMD
|
12.24 | $ 13.26 | -1.89 % | $ 857 M | Israel |
 |
OrthoPediatrics Corp.
KIDS
|
-7.8 | $ 33.43 | -1.65 % | $ 784 M | USA |
 |
Outset Medical
OM
|
-30.87 | $ 4.22 | 2.43 % | $ 64.2 M | USA |
 |
PAVmed
PAVM
|
-9.72 | $ 1.64 | 0.31 % | $ 1.1 M | USA |
 |
Sintx Technologies
SINT
|
-109.03 | $ 1.56 | 4.36 % | $ 4.33 M | USA |
 |
AVITA Medical
RCEL
|
-86.16 | $ 17.62 | 2.92 % | $ 491 M |  Australia |
 |
Tandem Diabetes Care
TNDM
|
-23.23 | $ 18.7 | 2.92 % | $ 1.27 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
-323.35 | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-43.02 | - | -1.42 % | $ 435 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-17.05 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-8.55 | - | - | $ 462 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-31.81 | - | - | $ 955 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-1.64 | $ 7.72 | 4.97 % | $ 1.04 B | USA |